Atala Financial Inc

Position in GILD — Gilead Sciences, Inc.

CIK 2053756 CALABASAS, CA

Position in GILD

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$233,855

-$24,118 QoQ

Shares Held

1,851

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#1,828

of 2,266 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Atala Financial Inc holds $1,854,323 across 4 Drug Manufacturers - General names. GILD ranks #4 (12.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	537	$644,093
2	JNJ	Johnson & Johnson	2,122	$538,924
3	BMY	Bristol Myers Squibb Co	7,592	$437,451
4	GILD	Gilead Sciences, Inc. This page	1,851	$233,855

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$233,855	1,851	0.0%	Shares	Sole	2026-07-23
2026-03-31	$257,973	1,851	0.0%	Shares	Sole	2026-04-10
2025-12-31	$227,191	1,851	-4.3%	Shares	Sole	2026-01-23
2025-09-30	$214,785	1,935	0.0%	Shares	Sole	2025-11-04
2025-06-30	$214,533	1,935	0.0%	Shares	Sole	2025-08-07
2025-03-31	$216,816	1,935	-4.9%	Shares	Sole	2025-04-23
2024-12-31	$187,972	2,035	—	Shares	Sole	2025-02-10
No filing history on record for this holder in this stock.